SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (245)1/30/1997 5:47:00 PM
From: Miles Rhyne Hoffman, CFA   of 6136
 
Thanks John. Excellent point about Mkt Caps. While I have a MISTAKEN impression that I get more bang out of my bucks buying lower priced stocks (a recent study showed high price stocks can make just as high a percentage return as lower priced), I just find it hard to buy a hundred or two shares of an $85 when I can get a 500 share block of a $32 stock. While I have been scared of AGPH higher per share value (fear of heights!), the market cap is the key, and since AGPH seems to have great potential, I guess I'm just going to have to bite the bullet and buy.

Thanks again.

Miles

PS: Rick, thanks for enlightening the GILD thread.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News